SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published:March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like MICAL2 enzyme found to promote tumor growth in pancreatic cancer January 2, 2025 Researchers develop magnetic nanoparticles for precise cancer treatment March 6, 2025 Mayo Clinic partners with Microsoft Research and Cerebras to revolutionize AI in healthcare January 15, 2025
Mayo Clinic partners with Microsoft Research and Cerebras to revolutionize AI in healthcare January 15, 2025